Prichek-GMP 1 Tablet ER
Marketer
Indoco Remedies Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Prichek-GMP 1 Tablet ER
Glycemia-Control ER 1mg is a dual-action formulation designed to manage blood glucose. This medication, used in conjunction with a healthy diet and regular physical activity, enhances glycemic control in adult patients with type 2 diabetes. It optimizes insulin effectiveness, resulting in reduced blood sugar. Glycemia-Control ER 1mg should be administered precisely as prescribed by your physician, taken with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; in this case, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic agents, alcohol consumption, or meal skipping may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial. Commonly reported side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function will be assessed by your doctor before initiating therapy. Limit alcohol consumption while on this medication to mitigate potential side effects.
Uses of Prichek-GMP 1 Tablet ER
Managing Type 2 diabetes
Major Benefits of Prichek-GMP 1 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Prichek-GMP 1 Tablet ER with a meal.
Common Side effects of Prichek-GMP 1 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Prichek-GMP 1 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Prichek-GMP 1 Extended-Release Tablet should be administered with a meal.
How Prichek-GMP 1 Tablet ER works:
Prichek-GMP 1 Tablet ER unites three distinct antidiabetic agents: glimepiride, metformin, and pioglitazone. These medications employ diverse actions to optimize blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Prichek-GMP 1 Tablet ER and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The extended-release Prichek-GMP tablet carries potential risks during pregnancy. While human data is scarce, animal research indicates possible harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Prichek-GMP tablet (1mg) likely poses a safety risk for breastfeeding individuals. Available human data indicates potential transfer to breast milk, with possible adverse effects on the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Prichek-GMP 1 Tablet ER, potentially requiring a modified dosage. Consultation with a physician is essential. Prichek-GMP 1 Tablet ER is contraindicated in individuals with severe kidney disease. Regular assessment of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Prichek-GMP 1 Tablet ER cautiously, potentially requiring dosage modification under medical supervision. Prichek-GMP 1 Tablet ER is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Prichek-GMP 1 Tablet ER :
Should you forget a dose of Prichek-GMP 1 Tablet ER, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Prichek-GMP 1 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


